Company intelligence
The diaTribe Foundation
Making sense of diabetes.
About The diaTribe Foundation
The diaTribe Foundation aims to empower readers with valuable, actionable information that inspires hope for a better future and helps them lead happier, healthier lives. The diaTribe Foundation was founded by Kelly Close, whose passion for diabetes stems from her extensive professional work and personal experience living with diabetes for over 35 years. From 2006 to 2021, she served as editor-in-chief, overseeing the nonprofit’s website and weekly newsletters. Since 2002, she has also led Close Concerns, a healthcare information firm specializing in scientific, regulatory, and advocacy developments related to diabetes and obesity. In 2009, she founded dQ&A, an insights partner that works with companies to drive more confident diabetes decision-making. As a result of her legacy, today diaTribe newsletters are sent weekly to more than 600,000 people with diabetes and their families.
Verified activity
Signals from The diaTribe Foundation
4 published signals
Products & Services
The diaTribe Foundation announced that Glooko launched its new GestationalCare feature bringing pregnancy-specific glucose targets to CGM data live in the UK and the US this October.
Reported by The diaTribe Foundation
Legal & Regulatory
The diaTribe Foundation announced that Mounjaro received FDA approval to cut heart attack, stroke, and cardiovascular death risk in type 2 diabetes.
Reported by The diaTribe Foundation
Legal & Regulatory
The diaTribe Foundation reported that the FDA authorized Abbott's Libre Duo 10 Day sensor to continuously track glucose and ketones at once, serving as an early warning system for DKA.
Reported by The diaTribe Foundation
People
The diaTribe Foundation is announcing that applications for the Global Summit and Walk-Off activity close on September 30, 2026.
Reported by The diaTribe Foundation